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RETINAL VASCULAR OCCLUSION 
Venous occlusive diseases has been the most common retinal 
disease found  in   clinical practice. Depending on the involvement site 
and retinal perfusion extent, venous occlusions affecting the retina have 
been classified into 6 clinical entities differently,
(1-4)
       
VENOUS OCCLUSIONS OF RETINA ARE CLASSIFIED AS: 
1) Central  Retinal Vein Occlusion (CRVO) 
a)  Non Ischemic or Venous Stasis Retinopathy 
b)  Ischaemic or Haemorrhagic Retinopathy 
2)  Branch Retinal Vein Occlusion (BRVO)  
            a)  Major  
                    b)  Macular 
3)  Hemicentral Retinal Vein Occlusion (HCRVO) 
                 a)  Non Ischaemic  
                    b)  Ischaemic        
 
 
About  50 % to  70 %  of the patients with CRVO are above 
50years of age and many have been  reported to  have an association with  
systemic Hypertension, Diabetes and cardiovascular disease. 
 
ANATOMY OF RETINA 
Retina, being a thin, and transparent membrane, is the inner part of 
the eyeball. And  this tissue  of the eye is the most highly developed 
structure. Retina, which has a surface area of 266 square mm, has an 
extension from the optic disc to oraserrata. Ophthalmoscopic examination 
when viewed grossly it is been divided into three regions
(5,6) 
: 
a) Optic disc,  
b) macula lutea, 
c) peripheral retina or general fundus. 
 
 
 
 
 
 
CENTRAL  RETINAL VEIN 
The Central Retinal Vein seen  on the optic nerve head is formed  
by the union of  tributaries of retinal vein.The vein is enclosed in a 
fibrous envelope along with the artery in common and it courses on the 
lateral side with central retinal artery usually in its axial part. 
The site where the vein exits from the optic nerve varies and it 
usually exits from the same aspect that of the nerve where the point of 
entry occurs with of the central retinal artery in about 42 % of the patients 
and the vein is found to be anterior to the artery in about 81 % . 
The intra vaginal course is 3.8-8 mm and it is longer than of the 
artery with a greater fraction of the course in the dura mater. 
TRIBUTARIES OF THE VEIN:  
1. From the Retina. 
2. From  the posterior central vein.  
3. From the optic nerve head including choroidal tributaries and from 
the peripapillary sclera at all levels. 
 
 
 
 
Communications : -  
The central retinal vein before it drains into inferior or superior 
ophthalmic veins and directly into  cavernous sinus joins the orbital 
plexus of veins.  
Blockage of blood flow does not occur in the central retinal veins 
when there is block in blood flow at cavernous sinus due to the multiple 
connections. 
 
Structure of Central retinal vein 
The central retinal vein which lies on the basement membrane has 
an endothelium which is continuous.Outside of this, it is a cell which may 
be a pericyte or  a smooth muscle and the tunica media is represented as a 
smooth muscle cell that is separated from the underlying tissue.  There is 
the presence of   connective tissue adventitia in it. 
 
 
 
 
 
 
CENTRAL RETINAL VENOUS OCCLUSION 
Central Retinal Vein  occlusion  or  among with its branches causes 
an   ischaemic infarct of the  retinal tissue that is already affected. 
Two types of Central Retinal Vein Occlusion are clinically 
described
(3,4,7) 
: 
Central Retinal Vein Occlusion in the ischemic variety constitutes 
to  20 - 25 percent among all  the cases while the major  percentage of  
about 75 - 80% eyes with Central Retinal Vein Occlusion are of non 
ischemic variety. 
Demographic characteristics: 
Studies conducted variously have shown that males are more 
commonly affected than  that of females
(7,8)
. The age of onset  are 
variable, between 14 to 92 years
(7-10)
. The ischemic type   more  
commonly occurs in people above 65 years while the nonischemic  
variety is of  more common occurence in patients below than 45 years. 
The involvement  risk of the fellow eye is  of 5.6 - 6.6 percent in  
duration of  2.8 - 3.4 years in  both the  types of Central Retinal Vein        
Occlusion 
(4,7)
. Developmental risk of  both types  of venous occlusion in 
the fellow eye is in range of 11.9 percent in a duration of 4 years
(7)
. 
 
 
Nonischemic variety can occur  repeatedly  in the same eye of  2.2 
percent only with  patients in duration of 5 years
(7)
 
PATHOGENESIS: 
Green along with Coinvestigators
(11)
, described in their 
histopathological  investigations,  and  accepted  the hypothesis  that  
formation of thrombus  was the  event  primarily  responsible  for CRVO.  
Proliferation of  Endothelium  and inflammation were the  common 
associations, but  they were believed to be in occurance in  secondary to 
formation of  thrombus  rather than of  primary events. The reason was 
unknown that whether the  formation of  thrombus occured in the region 
of Lamina cribrosa. 
The  formation of thrombus  in the region of lamina cribrosa  was 
the  close anatomic association  of  the Central Retinal  Vein with the 
Central Retinal Artery in  this region  as well as the  narrow course of 
Central Retinal Vein through it  contributes to  the turbulence of  flow 
and formation of thrombus 
(12)
.  
 A common adventitial sheath  is shared by  the central retinal 
artery along  with the vein as they leave the head  of  optic nerve and 
passes  along a  narrow opening in the  region of the lamina cribrosa. 
 
 
Because of  the narrow entrance in the  region of lamina cribrosa, 
the vessels are in situated in a compartment  which is tight and  with a 
limited space for  it to displace. This  critical  anatomical position 
predisposes to the  formation of thrombus  in the Vein by  some  major  
factors  including slowness  of  blood stream, changes occurring  in the 
wall of the vessel and blood changes. 
Virchow’s classical triad   described in thrombus  occurance are : 
1.  Slowing  occurring in blood stream 
2. Changes in the wall of the vessel. 
3. Blood rheology Changes . 
Klein  along with Olwin
(13)
 and Klein
(14)
 , made postulations for  
the following mechanisms  of pathogenesis  that  contributes to  Central 
Retinal Vein  blockage causing  stagnation of  flow in the vein and result 
in a primary thrombus  occurance. 
1. Blockage of the vein externally by the sclerosed central retinal 
artery, which is enclosed in same sheath and endothelial  
proliferation  occurring  secondarily. 
2. Blockage by primary venous wall disease  which is degenerative or 
inflammatory in origin. 
 
 
3.  A variety of factors produce  haemodynamic disturbances like  
subendothelial atheromatous  causes  in the central retinal artery, 
spasm of the artery , arterial hypotension, dyscrasias of the blood, 
that  is aggravated further by arteriosclerosis or anatomic relations  
which is unfavourable. 
Hayreh 
(15)
, produced  different  types  of retinal vascular blockage 
in rhesus monkeys, to establish the pathogenesis of Central Retinal Vein 
Occlusion. 
Central Retinal Vein Occlusions lead  to the stagnation of the blood 
in the retinal vein system and increased resistance  in it causes  stagnation 
of  blood and also  ischaemic damages to the retina. 
It has  been  postulated that ischaemic damages to  retina 
stimulated the VEGF production increase  in the vitreous cavity. 
The Increased levels  in VEGF stimulated  the  neovascularisation 
of    anterior and  posterior segment that was  responsible for the 
secondary complications in  CRVO. 
Also , VEGF can cause  capillary leakage that will lead to macular 
edema 
(16)
 was shown , and this found to be the leading cause of visual    
loss in both ischaemic group and non  ischaemic type in  CRVO. 
 
 
CLINICAL CHARACTERISTICS SEEN IN ISCHEMIC AND NON 
ISCHEMIC  GROUP OF CRVO: 
 
Clinical 
Characteristics 
ISCHEMIC CRVO 
 
NON-
ISCHEMIC 
CRVO 
1. Vision   
Usually it is 
markedly impaired. 
mildly impaired. 
2. 
Relative Afferent 
Pupillary Defect 
Present Absent  
3. 
Visual Fields 
examination 
Peripheral fields-
Abnormal 
Normal -
peripheral fields. 
4. 
Fundus Fluorescein 
Angiography 
Extensive 
Capillary Non-
perfusion -More 
than 10 disc areas 
Nil or  minimal 
Capillary Non-
perfusion. 
5. 
 Neovascularisation 
seen 
Present Not present 
6. Electro Retinogram 
Decreased b wave 
amplitude and  
decreased b/a ratio. 
Normal b wave 
amplitude and  
Normal b/a ratio. 
 
 
 
RISK FACTORS AND ASSOCIATIONS OF RETINAL 
VEIN OCCLUSIONS ATTRIBUTED
(17,18,19)
 : 
SYSTEMIC DISEASES  AND  CENTRAL VEIN OCCLUSION: 
Certain systemic diseases  can influene  the  formation of  the thrombus in 
the central retinal vein : 
A )    External compression . 
B )    Primary formation of thrombus  through  disorders of the  blood. 
C)     Inflammatory and  degenerative conditions of the vein itself. 
EXTERNAL COMPRESSION:  
Hypertensive  or arteriosclerotic changes  in the central retinal artery  
could compress the vein as  they  pass through  the region  of  lamina  
cribrosa through  a  common  sheath.(13)When this process is 
exacerbated by  stagnation of the venous blood, a secondary thrombus 
forms and this leads to the occlusion of the vein. Other causes of external 
compression includes  papilledema, papillitis , graves  disease , orbital  
space occupying lesions  and  retro- bulbar intra nerve sheath 
injections.(18, 64) 
 
 
 
HAEMORRHEOLOGICAL FACTORS : 
Various factors  in the constituents of blood  can predispose to formation 
of thrombus  in the blood such as high viscous nature of the blood, 
increased coagulability  and  reduced thrombolytic state. Increased  
viscous nature of the blood associated with  raised haematocrit  values 
has been reported  in patients  with retinal vein blockage and  had been 
compared with controls(27). 
PRIMARY DISEASE IN THE VESSEL WALL : 
 Infectious  causes of vasculitis like syphilis  and AIDS and systemic  
vascular diseases  like  connective tissue  disorders  have an association 
with occlusion of the  retinal vein(37) .Localised inflammations of the 
vein could lead to occlusion of the vein  like in sarcoidosis and the 
diseased wall could interact with  the clotting factors leading to the 
formation of the thrombus. 
1). Systemic vascular diseases : –  
Diabetes Mellitus, systemic Hypertension, Insufficiency Of 
carotid artery. 
 
 
 
 
 
2). Ocular Diseases : –  
Glaucoma of Open Angle type, Ischaemic Optic 
Neuropathies,  Drusen of the Optic Nerve head  and Pseudo tumour 
cerebri. 
3). Haematologic Alterations:–  
Syndromes  due to Hyperviscosity, Dysproteinemias, 
Multiple Myeloma, Blood dyscrasias like Polycythemia Vera, 
Lymphoma, Sickle Cell diseases, Anaemia, Elevated plasma 
homocysteine, deficiency of  factor xii, Antiphospholipid antibody 
syndrome, Activated protein C resistance, deficiency  of  Protein C, 
deficiency of  Protein S. 
4). Inflammatory and   Auto immune Vasculitis : –  
Autoimmune mediated disorders like Systemic lupus 
erythematous.                                                                            
5). Medications : –  
Oral Contraceptives, Diuretics and  Hepatitis B Vaccine. 
 6). Infective Vasculitis :– 
           HIV and  Syphilis, Herpes Zoster, Sarcoidosis. 
 7). Others: –  
           After retrobulbar block, Dehydration,  during  Pregnancy. 
 
 
 
ASSOCIATED MEDICAL CONDITIONS s: 
1).  Hypertension : -  
Hypertension is  found to be one of the most common cause 
of CRVO  occurring   in older patients. 
The eye disease Casecontrol study 
(20)
 found  that an 
increased risk  occurred in  any type of Venous occlusive 
disease  in those patients with Systemic Hypertension and 
DM. 
Persons with  non-perfused Venous occlusive disorders had 
an  odds-ratio that is   greater, implicating   where in systolic 
and diastolic Hypertension  are risk factors  compared to a  
perfused Venous occlusive disease. Similar associations 
were found with  the  other prospective and retrospective 
cross-sectional studies with Systemic Hypertension. 
2). Diabetes Mellitus :-  
One of the  other  leading cause of CRVO  found  in adults 
was Diabetes which caused  microvascular angiopathy and 
thrombo-embolic phenomenon. Several  authors
(21,22,23)
 have 
 
 
reported the incidence of diabetes in patients with CRVO to 
found to  vary from   13 – 34%. 
Prevalence of Diabetes mellitus is found to be more in 
individuals with a non-perfused central retinal vein blockage 
than matched controls from large population database  study. 
3). Hyperlipidemia :- 
Association of hyperlipidemia with central retinal vein 
occlusion has been reported. The incidence has been found 
to be low in previous reports
(24,25)
 . 
More emphasis has been laid recently, on detecting 
hyperlipidemia in these patients as the incidence is 
constantly increasing. Raised cholesterol Patients are put 
under high risk group. 
 
4).  Hypercoagulability : -  
Haematological  abnormalities, conditions  particularly that 
predispose to a hypercoagulable state, has  been identified in 
persons with central retinal vein blockage. Individuals below  
60 years of age were found to have a greater association with 
increased coagulable states and inflammatory nature, 
 
 
compared with that of older age group with a higher 
incidence of systemic vascular disease risk factors.  
Lahey with his investigators  found only one  lab value 
outside normal limits in fifty-five  patients that contributed 
to 27 %, younger than 56 years, suggesting  the  systolic 
high coagulable states
(26)
. 
Studies have demonstrated that an increased incidence of 
coagulation cascade abnormalities was found including 
resistance of  protein C ,factor P. Leiden presence , presence 
of antiphopholipid antibodies and  fibrinogen levels that was 
abnormal. 
(27,28,29,30, 31)
. 
In a meta-analysis of studies that was published, an 
association was  found with raised  plasma homocysteine 
and low serum folate levels, but not with  serum Vit. B12 
levels and the thermo labile methyl tetrahydrofolate 
reductase genotype
(32)
 and same was  observed with  
increased viscosity from blood dyscrasias  ,dysproteinemias  
and  dehydration  in  central retinal vein occlusion
(33)
 . 
 
 
 
5). Migraine : -  
Friedman MW 
(34)
 in his study found that nine percent  of 
patients who had headache was due to migraine and 
speculated that it was  related to platelet abnormality. 
Fong et al
(35)
 in his series,  observed  that  4 out of 102 (4%) 
cases and that of Walton,  spalton, found  2 out of 17 (12%) 
of the patients suffered  from   migraine. 
 
6).   Mitral Valve Prolapse:- 
Gorden et al
(10)
, reported  in his study ,7 out of 11 patients 
with occlusion of  central retinal vein showed evidence of 
Mitral Valve Prolapse. The authors suggest that 
hyperactivity  of the platelets  is the leading cause of central 
retinal vein occlusion in  these patients. 
 
7).   Collagen Vascular Disorders:- 
Collagen Vascular Disorders  are  seen in association  with 
retinal vascular disorders
(25,36)
, of which SLE is  known  to 
 
 
cause an inflammatory reaction  in blood vessels including  
those of retina. 
8).   AIDS : -  
Teiaer and Sonnaberd
(37)
  reported on  a case of central 
retinal vein occlusion in an  AIDS patient  and postulated 
that it might  be due to high  levels of  anticardiolipid 
antibody , immune complex deposits or a toxic direct  effect 
of HIV virus on  the endothelium and thus perivasculitis  
may be a part of non – infective AIDS retinopathy. Others 
have also reported occlusion  of central retinal vein in 
association with AIDS
(18)
. 
9).   Carotid Artery Disease : -  
Brown et al
(38) 
 demonstrated atherosclerosis of the  Carotid 
Artery by Digital Substraction Angiography in 3 patients 
with Ischemic type of  central retinal vein occlusion.  
Lazzarro
(10)
, reported 6 out of 12 patients can  have central 
retinal vein occlusion . 
 
 
 
 
10).  Medications : - 
a) Oral Contraceptives : -  
 Many reports have shown a trend towards 
hypercoagulability with the usage of oral contraceptives, 
Kulvin et al
(10)
 performed an  experimental study on 
monkeys with oral contraceptives and observed  the  
dilatation of Central retinal  vein. Stowe 
(39)
 et al showed the 
occurrence of intimal proliferation with occlusion in patients 
who took oral contraceptives for about  4 years. 
b) Diuretics :- 
 Gutman
(18)
 suggested that patients  who received 
diuretics may be at risk of developing central retinal vein 
blockade  due to secondary heamoconcentration effect  that   
lead to hyperviscosity. 
OCULAR CONDITIONS:- 
Magargal et al
(40)
 reported 16 out of 69 (25%) of their patients had 
associated ocular abnormalities. 
 
 
 
 
 a).  Glaucoma :-  
Glaucoma usually of primary open angle type, is well known 
to predispose to central retinal venous occlusion in patients 
of elder age group. Incidence of chronic open angle 
glaucoma seen in cases of central retinal vein occlusion has 
been reported to range from 66 to 75 %. Mansour et al 
(59)
 
and Strabhlman et al
(10)
 found  that no relationship existed  
between cup-disc Ratio and central vein occlusion. 
b).   Other ocular conditions  that  caused  deformation or 
mechanical pressure  on  the optic nerve head and lamina 
cribrosa were  Ischemic Optic Neuropathy, congenital 
abnormality  of Nerve head, drusen of the  Optic Nerve head, 
Optic  disc traction syndrome and pseudotumor cerebri, and 
these were  found to have associations  with Central Vein 
Occlusion. 
 
c)     External compression of the globe and  also optic nerve 
from thyroid related  Ophthalmopathy  or mass  lesion or a  
patient with head trauma and  orbital fracture  may also 
result in Central Vein Occlusion. 
 
 
 
NATURAL COURSE SEEN IN CENTRAL 
RETINAL VEIN OCCLUSION 
The retinopathy of   Central Retinal Vein blockage  generally is 
self-limiting and gets  resolved  over a period  from weeks to years. Some 
of these eyes  are likely  to develop the following complications: 
 
1).    Macular Edema: 
Macular dysfunction  is  seen to  occur  in most  of the eyes with 
Central Retinal Vein Occlusion, that  leads  to  central visual loss. In eyes 
with nonischemic  type of  Central Retinal Vein Occlusion, the resolution 
of macular microcystic edema  can be slow, without any residual  loss of  
visual acuity 
(4).  
In  few  patients,the macular edema  in chronic duration  can 
progress  to  multiple permanent structural changes in macula like  
cystoid macular degenerations ,  macular  pigmentary  disturbances   and   
epiretinal membrane. 
 
 
 
 
 
2).   Ocular Neovascularization: 
This is  known to be  one of the serious complication  seen in 
ischemic  type  of Occlusion of  Central Retinal Vein. The site of 
common occurence is the iris and the angle  then followed by the optic 
disc and  peripheral  retina. About onethird of the eyes with iris 
neovascularisation  was found  not to develop neovascular glaucoma. 
 
The reported incidence overall of Neovascular Glaucoma in 
ischemic variety  of  Central Retinal Vein Occlusion was  found to vary  
from  14 - 60 percent  widely.
(4, 41-44)
. However, it is seen  that every eyes 
with ischemic variety of CRVO do not develop  ocular  
neovascularisation but  the  risk  is  very high in the first seven months  
after the onset  of the  disease . It is  observed in some patients that who 
had severe pain due to neovascular glaucoma at the initial visit had a 
history of visual loss three to four  months  before. This condition  was 
named as “100 days glaucoma” and these patients  typically presented 
with corneal edema,elevated intra-ocular pressure,severe 
neovascularisation of the iris, and  closed angles on gonioscopic 
examination. 
 
 
 
The study of Hayreh et al suggested that severity and   nature  of 
extent of retinal ischemia were the principal factors, though the follow-up 
duration also played  a role in the incidence of ocular Neovascularization. 
However, it is also known that 23  to  42 percent of  eyes with Central 
Retinal Vein block  might  have a pre-existing glaucoma or 
hypertension
(45-47)
. Neovascular glaucoma was not reported in non 
ischemic  type  of  Central Retinal Vein Occlusion, unless  when it was 
associated with an underlying diabetic retinopathy, carotid artery disease, 
or any other  retinopathy  with extensive capillary blockage.
 
 
 
3).  Vitreous Haemorrhage: 
    Vitreous hemorrhage in Central Retinal Vein  blockage was found 
to have an  incidence  of up to 7 percent
(42,44)
. Neovascularization was 
found not as the only cause of vitreous hemorrhage, and the other 
common causes were the leakage of blood through internal limiting 
membrane
(4)
 of retina in the early stages of Occlusion. The  haemorrhage  
can   also  occur sometimes  due to intra – retinal  abnormalities in  the  
microvasculature secondary to occlusion of the vein  and due to  posterior 
vitreous  detachment.  
 
 
 
 
4).  Cilioretinal Artery Occlusion: 
One of the major contributing factor of severe visual loss in  
nonischemic  type of Central Retinal Vein Occlusion was the associated 
cilioretinal artery occlusion. This might have caused a permanent field 
defect, which can be sectoral or centrocecal, depending on  nature of  the 
extent of involvement
(4)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
1). Prevalence and  Risk factors of Occlusion of  Retinal Vein in an 
Asian population. 
Br. J. Ophthalmol 2008; 92:1316-1319. 
 L.L.Lim, N. Cheung, J.J Wang et al
(48)
,  conducted a population 
based, cross-sectional study, the Singapore Malay Eye study consisting of 
3280 (78.7%) malay adults aged  40 to 80 years .The results  of the study 
showed that Retinal Vein Occlusion was associated with raised systolic 
levels   of blood pressure  in individuals with a  history of angina,  or 
increased  total cholesterol levels and heart attack. 
2). 
 Paul Mahoney, Wong DT, Ray JG et al
(49)
, systematically reviewed  
all studies between January 1985 and July 2007 that compared cases with 
any form of Retinal Vein Occlusion with controls. They generated pooled 
odds ratio (OR) and estimates of the population with  attributable risk 
percentage for systemic hypertension, hyperlipidemia and diabetes 
mellitus. 
 The results observed from the twenty-one  studies, including 2916  
patients  and 2864 controls, showed that both hypertension (OR, 3.5; 95% 
 
 
Confidence interval [CI] 2.5 – 5.1) and hyperlipidemia [CI, 1.7 – 3.7] 
were significantly associated with any form of Retinal Vein Occlusion. 
 The percentage of cases with any form of Occlusion  of  Retinal 
Vein  that  was   attributed to hypertension   were  47.9% (95% CI, 31.2% 
- 63.1% )TO Diabetes Mellitus was 4.9% (0,8% - 11.5%) and to 
hyperlipidemia 20.1 % (, 5.9% - 43.8%). 
 Thus, the study concluded that hypertension and hyperlipidemia 
are the most  common risk factors in adults for Retinal Vein Occlusion 
and diabetes mellitus is lesser . It also concluded that lowering of blood 
pressure and / or Serum lipid  levels can improve the   visual acuity or the 
complications of Retinal Vein Occlusion has to be determined. 
 
3). Ocular Neovascularisation Associated with both CRVO and 
HCRVO. 
  Retina 32:1553-1565, 2012 
        Hayreh SS, Zimmermann et al
(50)
,  in their study on 912 (673 Non-
ischemic type  and 239 Ischemic type )cases  with CRVO and HCRVO 
investigated the incidence of ocular neovascularisation in CRVO and 
hemi central  vein occlusion. Ophthalmic evaluation was done at initial 
 
 
and  every visits which included the  testing of vision, examination of 
fields, thorough   anterior  segment,  fundus examinations and  fundus 
fluorescein angiography. 
       The results of the study  also  showed that in ischemic variety  of   
crvo, within 6 months  duration from time of onset, the probability of 
development of iris neovascularisation was  49  percent, 
neovascularisation  at the angle is 37 percent, neovascular glaucoma 29 
percent, and disc neovascularisation  6 %. More severe peripheral retinal 
haemorrhages were significantly associated with Iris Neovascularisation 
(P is  0.005); Angle Neovascularisation (P is 0.0004)  and Neovascular 
Glaucoma (P is 0.012). 
  
This study finally concluded that in Ischemic type of Central 
Retinal Vein Occlusion, neovascularisation  of the  anterior segment  was  
much more common than posterior segment Neovascularisation and the 
cumulative chances  of developing the change  is maximum within the 
first 6 months. 
 
 
 
 
4). Natural History of  the visual outcome in CRVO. 
Ophthalmology  vol :118 . no.1 January 2011. 
Hayreh  SS  et  al, Patricia  A ,Podhajsky et al
(51)
,  investigated    
the  natural history of visual acuity outcome in Central  Vein Occlusion, 
and  systematically  reviewed in six-hundred sixty seven consecutive  
patients  with  30 patients having  both eyes resulting in 677 eyes  with 
Central Retinal Vein blockage  from 1973  till  2000. 
      Visual evaluvation was carried out in all patients by recording 
vision  using Snellen’s acuity chart, assessing the visual fields with a 
Goldmann perimeter. The same ophthalmic evaluation was performed at 
each  consecutive visit. Occlusion of  Central Retinal Vein was classified 
as  Non-Ischemic  variety with 588 eyes  and Ischemic  variety with  109 
eyes  at an initial visit based on the functional and morphologic data. 
 The results of the study showed that within the  first three months, 
visual acuity was 20/100 or better 78  percent in  Non-ischemic cases of  
Central Retinal Vein block   and only on 1 percent  with Ischemic cases 
of  Central Retinal Vein Occlusion (P was  0.0001) and visual defects 
were minimal in 91 percent  and 8% (P is  0.0001).  
 
 
 Final visual acuity was 20/100 or better in 83percent of cases   on 
resolution of Macular edema in Non-ischemic variety of  Central Retinal 
Vein Occlusion, and only 12% with Ischemic  type of Central Retinal 
Vein Occlusion (P was  0.0001) and defects  in visual field was minimal 
or mild in 95 percent  and 18% (P is 0.0001). on resolution of macular 
edema, eyes with initial visual acuity of 20/70 or worse, vision improved 
in 59 percent  with Nonischemic  type  of  Central Retinal Vein block, 
with no significant improvement in Ischemicvariety of  Central Retinal 
Vein Occlusion (P is  0.55). 
 Also, with  resolution of Macular edema, eyes with moderate to 
severe defect in  visual field, improvement was seen in 86 percent  of 
Non-ischemic type  of  Central Retinal Vein block, but no improvement 
was seen in eyes with Ischemic  variety  of  Central Retinal Vein 
Occlusion (P is 0.83). 
 In Nonischemic  variety of  Occlusion  of  Central Retinal Vein , 
development of final pigmentary degenerative changes, epiretinal 
membrane formation  and or both was the main cause of poor final 
visualoutcome. This showed that initial presentation and the final visual  
acuity outcome in 2 types of Central Retinal Vein Occlusion are entirely 
different. 
 
 
The study concluded that differentiating  central  Vein Occlusion 
as Non-ischemic and Ischemic types, are  based on  the functional criteria 
and was mandatory and fundamental in determining the  visual outcome. 
Visual  acuity outcome was good in Nonischemic type  and poor in 
Ischemic type of  Central Retinal Vein Occlusion. 
  
5) .Natural history of the Central Retinal Vein Occlusion-: An 
evidence based systematic review approach. 
Ophthalmology 117, No.6 June 2010. 
McIntosh, Sophie L, Rogers, Ning Cheung et al
(52)
, systematically 
reviewed case series   for 5 years to describe the natural history of Central 
Vein Occlusion. 
 Two investigators identified all the observational studies  that 
evaluated the natural history of Retinal Vein Occlusion and all clinical 
trials evaluating interventions for Central Vein Occlusion, an untreated 
control arm was included. 
 This study reviewed 5966 citations, also 53 studies providing 3271 
eyes with Central Vein Occlusion for the  analysis of its natural history. 
 
 
Visual outcome  was poor at baseline (20/40) and decreased further over 
time.  
Although some studies reported an improvement in Visual acuity, 
none of these improvements resulted in visual outcome, better than 20/40. 
Upto 34 percent  of the eyes with Nonischemic  type  converted to 
Ischemic variety of Retinal Vein Occlusion over a 3 year period. In 
Ischemic Retinal Vein Occlusion cases, Neovascular glaucoma developed 
in 23 percent of eyes in 15 months. In Non-ischemic variety, , macular 
edema  was resolved in 30% of eyes approximately over time, and 
subsequent neovascular glaucoma was rare in occurance. Thus the study 
concluded that untreated eyes with Central Vein Occlusion had  in 
general   poor vision   and  it   declined further over time. One quarter of 
eyes with Nonischemic  variety  was found to convert to Ischemic- 
variety of   Central Retinal Vein Occlusion. 
6) .Retinal Vein  Occlusion. 
Indian Journal of Ophthalmology 1994;42:109-132. 
 In this study, Hayreh SS
(53)
,  has discussed about the recent 
advances and classification of Retinal Vein Occlusion, the pathogenesis 
and demographic characteristics of various types of Retinal Vein 
Occlusion; differentiating   Nonischemic  type and Ischemic type of   
 
 
CRVO based on six entities like testing vision,  examination of  visual 
fields, Relative afferent pupillary defect, Electroretinogram, 
Opthalmoscopy and Fundus Fluorescein Angiography; the course and 
management of  the   various types of Retinal Vein Occlusion. 
 
7) . Atherosclerotic and thrombophilic risk factors found in patients 
with Ischemic CRVO. 
Retina 2011 April;31(4):724-729. 
 Sodi, Giambene B, Marcucci R, Sofi F et al
(54)
,  studied in one 
hundred and three patients with  acute CRVO that was unilateral  in 
presentation with 41 Ischemic  type  and 62 Non-ischemic type.. The 
frequency of traditional cardio-vascular risk factors were analysed   and 
plasma levels of a variety of thrombophilic markers were measured. 
 The results of the study showed that arterial systemic  
Hypertension, Hypercholesterolemia, Postmethionine 
hyperhomocysteinemia and decreased  Folic Acid levels  were more 
frequent  in  occurance in  patients with Ischemic entity CRVO than in 
Non-ischemic entity.(P is 0.030; P is 0.011; P<0.001; and P=0.044 
respectively) 
 
 
 The risk factors for Ischemic type were arterial Hypertension (odds 
ratio [or], 3.32;; P=0.037) ,Hypercholesterolemia (OR, 3.03; 95% CI, 
1.06 – 8.65; P is  0.042), decreased  folic acid levels (OR, 6.77; 95% CI, 
1.59-28.79; P is  0.011).  
The study concluded that some atherosclerotic and thrombophilic 
risk factors may increase the risk of an Ischemic  type of CRVO. 
 
8) . High Lipoprotein (a) levels association with an increased risk of 
Retinal Vein Occlusion. 
Atherosclerosis 2010 May; 210(1):278-281 
 Sofi F, Marcucci R, Fedi S et al
(55)
,  compared 262 patients  with an  
median age of  66 years (5-88); 122 males and 140 females , with 261  
age and sex comparable healthy individuals. 
 They found that circulating concentrations of Lipoprotein (a) were 
found to be of  significantly difference  in patients when compared to 
healthy subjects - 189 (60-1898) mg per  L vs 119.5 (6-1216) mg per L ; 
P  less than  0.0001 respectively . No significant difference was observed  
with in  relation to different types of occlusion whether Central or Branch 
Occlusion.. In the Univariate analysis,Lipoprotein (a) levels  more than  
 
 
300 mg per  L were found to be associated with an higher  risk of Retinal 
Vein  Occlusion ( OR: 2.39, 95 percent  CI, 1.39 – 3.59; P  less than  
0.0001). Then three models  of multi-variate analysis were performed. In 
all the models, Lipoprotein (a) levels  more than   300 mg per  L 
confirmed its role as a risk factor for Retinal Vein Occlusion . first model, 
OR: 2.15 (95 percent  CI; 1.39 to 3.32), P is  0.001 ; second model, OR: 
3.11 (95 percent  CI 1.77 to 5.62), P  less than 0.0001; third model, OR: 
3.48 (95 percent  CI, 1.88 to  6.43), P  less than  0.0001] 
 Thus, this study reported that in a large population  with  Vein 
Occlusion patients, high  concentrations  of Lipoprotein (a) were 
significantly related to Occlusion which was independent from  the  other 
traditional and emerging risk factors, suggesting that they also might play 
a role in the   pathogenesis. 
 
9) . Risk factors in central retinal vein occlusion. 
Oftalmologia. 2011;55(2):27-37. 
Calugaru D
 
et al
(56)
,  in his study observed that risk factors for the 
occurrence of central   vein occlusion were to a limited extent   similar 
to those of cardiovascular diseases  like  arteriosclerosis, systemic 
 
 
hypertension, diabetes mellitus  and dyslipidemia. 
Hyperhomocysteinemia was found to be a part of an essential risk 
factor for arteriosclerosis intervening directly with the local 
mechanism that caused venous and arterial occlusions. Ocular 
hypertension and glaucoma were risk factors and significantly 
associated with pathogenesis of central retinal occlusion. Therapy with 
anticoagulants and platelet antiaggregating  drugs exposed the patient 
for development of central  vein occlusion influencing the visual 
outcome  adversely without having any evidence of  the  protective or 
beneficial effects. 
   
 
10).Etiology of  the  central retinal vein occlusion. 
        Oftalmologia. 2011;55(2):12-26. 
   Calugaru D et al
(57)
, In his another study has shown  that  
primarily arteriosclerosis was responsible for the majority of pictures 
of central  vein occlusion occurrence. The venous occlusions that 
occurred during    the development of the  known disorders already  
represented  venous occlusions secondarily. In young adults central 
retinal vein occlusion represented a nonspecific change in general that 
contributed to the emergence of Multifactorial causes  from a number 
 
 
of individual. Even In unusual cases of central vein occlusion the 
etiology was known but within the vast majority of patients the 
specific cause, even the causes that contributed  to the occurrence of 
this disease remains unknown, due to the  limitations of  ophthalmic 
literature and the  scarcity of histopathologic material. 
 
 
 
 
 
 
 
\ 
 
 
 
 
 
 
   AIMS AND OBJECTIVES  
1. To study the risk factors and systemic associations of CRVO in 
non-diabetic individuals. 
2. To compare the demographic factors (like age, sex) in nonischemic  
variety and  ischemic  variety of CRVO. 
3. To compare the final ocular outcome in ischemic and non-ischemic 
CRVO. 
4. To study the natural course of CRVO. 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS  
 A prospective clinical study was carried out to analyse the clinical  
course of CRVO in non-diabetic individuals. 
All suspected venous occlusion were screened at retina clinic of 
Govt. Rajaji Hospital for a period of one year. 
72 patients with vein occlusion were seen, out of which 40 eyes of 
40 patients satisfying the inclusion criteria were enrolled in the study. 
The patients were in the age group of 35 years to 75 years. There 
were 30 males (75%) and 10 females (25%) in the study group. 
The right eye was involved in 18 patients (45%) and left eye in 22 
patients (55%). 
Thorough medical history and general examination of the patient 
was carried out to rule out the presence of any systemic disease 
predisposing to a vein occlusion. In doubtful cases, expert opinion was 
obtained. A detailed ocular history which included history of any 
previous ocular disease and the treatment was elicited. 
 
 
 
 
TABLE : 1. 
Inclusion criteria : 
i) Confirmed presence of CRVO. 
ii) Non-diabetic individuals with CRVO. 
iii) Patients of all ages presenting with CRVO. 
 
 
TABLE : 2 
 
Exclusion criteria: 
i. Presence of Branch Retinal Vein Occlusion (BRVO), 
Diabetic retinopathy or any other retinal vascular disease or 
with vitreous haemorrhage. 
ii. Previous photocoagulation done for retinal vascular disease. 
iii. Any other external eye disease likely to affect the visual 
acuity during period of study. 
 
 
 
 
 
 
Baseline investigation was carried out immediately and thorough 
lab workup plan was carried as follows:- 
TABLE 3 : 
 
LAB  - WORK UP PLAN. 
- Haemoglobin. 
- Complete blood count (CBC). 
- Fasting Blood Sugar levels. 
- Post-prandial Blood Sugar levels. 
- Lipid Profile. 
- Blood Urea, Serum Creatinine. 
- Erythrocyte Sedimentation Rate (ESR). 
- Mantoux test. 
- Blood VDRL for Syphilis. 
- Coagulation Studies. 
- ELISA for HIV. 
 
 
 
 
 
 
Electrophysiological test:  
- Electrocardiogram 
- Echo cardiogram. 
- Carotid Doppler for selected patients. 
 
Ocular examination at the time of initial presentation of the patient 
included the following :  
 
i) Best corrected visual acuity. 
ii) Pupillary reaction 
iii) Slitlamp biomicroscopy. 
iv) Indirect Ophthalmoscopy. 
v) Fundus Fluorescein Angiography. (F.F.A.) 
 
The appearance of disc edema unilaterally with dilatation and 
tortuousity of major blood vessels of retina and varying amounts of 
retinal haemorrhage were said to have Central Retinal Venous Occlusion. 
 After the initial visit, patient was followed up every month for a 
minimum period of  6 months. 
 
 
 
The criteria chosen to classify the patient in ischemic and non-ischemic 
includes the following:- 
i) Poor visual acuity. 
ii) Presence of Relative Afferent  Pupillary Defect.   (RAPD). 
iii) Fundus showing extensive haemorrhages and cotton-wool spots. 
iv) Fundus Fluorescein   Angiography showing non-perfusion areas 
greater than 10 disc diameters. 
 
Those patients with Ischemic Central Vein Occlusion who 
developed neovascularisation of iris out of neovascularisation of disc and 
elsewhere were treated with pan retinal photocoagulation in two sittings 
while the remaining patients were followed up at monthly intervals upto 
the conclusion of the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                RESULTS 
 
 40 eyes of 40 patients who satisfied the eligibility criteria were 
included in the prospective study on the etiology and course of CRVO. 
 
 The study group consisted of 30 males (75%) and 10 females 
(25%); the male: female ratio being 3: 1. 
 
GENDER STUDY GROUP 
TABLE  1 
 Frequency Percent 
Male  30 75 
Female  10 25 
Total  40 100 
 
 
 
 
 
 
 
TABLE  2  : 
 
Number of cases Non-ischemic  CRVO Ischemic-  CRVO 
 FREQUENCY PERCENT FREQUENCY PERCENT 
MALES       20    71.4%     10   83.3% 
FEMALES         8    28.6%       2                      17.7% 
TOTAL       28    100.0%     12   100.0 % 
 
 
 Most of the patients  in our series  were found to be males  
contributing to  83.3% in ischemic variety and 71.4% in the 
nonischemic variety  with  females contributing    to  28.6  %  of 
the nonischemic patients and 17.7% of  ischemic group in the total.  
 In our study Non- ischemic CRVO patients are about 70% and 
Ischemic-CRVO patients are about 30% of the total. 
 
 
 
 
 
AGE –  DISTRIBUTION   
 
AGE  - STUDY  GROUP : 
 
TABLE  3  : 
 
  AGE  (YEARS )        FREQUENCY               PERCENT 
        35  -  44             2               5.0 
       45  -  54            10               25.0 
       55 -  64            18                45.0 
       65  -  74            10                25.0 
     TOTAL            40               100.0 
 
 
Demographic   study  shows  that  majority   of  patients  are in the 
age group of   55 – 75  years  (70% )  with  mean age = 58.3 years  ; SD = 
8.28;  in the  study  group. 
 
 
 
 
 
 
 
INITIAL PRESENTATION 
 
TABLE   4  :  
 
 
AGE 
  
NON-ISCHEMIC  - CRVO 
 
 
ISCHEMIC- CRVO 
 
  
FREQUENCY 
 
PERCENT 
 
FREQUENCY 
 
PERCENT 
35  -   44 2 7.15  % 0 0 
45  -  54 9 32.14  % 1 8.3 % 
55  -   64 14 50 .0 % 4 33.3% 
65   -  75 3 10.71 % 7 58.3% 
 TOTAL 28 100.0 12 100.0 
 
 Majority  of the patients with Non-ischaemic  CRVO were around  
55 to 64 years of age at initial presentation contributing to 50%  
 Most of the patients with Ischaemic CRVO were between 65 to 75 
years of age, contributing to 58.3 % 
 
 
 
 
III .     LATERALITY   : 
 TABLE     5  : 
 
              FREQUENCY        PERCENT 
RIGHT EYE             18        45 .0 
LEFT  EYE             22        55 .0 
 TOTAL             40        100 .0 
 
In our  observation , all our  study  cases  were unilateral with the 
right eye  affected  in  18  cases  ( 45 % )  and  left  eye   in  22  cases       
(55 %). 
  COMPARISION OF THE LATERALITY OF THE EYE 
AFFECTED IN NON ISCHEMIC GROUP, ISCHEMIC AND 
CONVERTED GROUP 
 
TABLE   6: 
  
NON-ISCHEMIC  
 
CRVO 
 
ISCHEMIC- CRVO 
 
 
 
CONVERTED 
NUMBER PERCENT NUMBER PERCENT NUMBER PERCENT 
 
 
RIGHT 
EYE 
 
14 
 
58.4% 
 
3 
 
25% 
 
1 
 
25% 
LEFT 
EYE 
 
     10 
 
  41.6% 
 
       9 
 
    75% 
 
      3 
 
     75% 
TOTAL      24   100.0      12    100.0       4    100.0 
 
In  our  study , right  eye  was affected  in  14  patients  of non- ischemic 
group contributing to  58.4 %  and  3 patients  in ischemic variety  with 
25 %. The  left eye  was affected  in 10 patients of  non- ischemic group  
and   9 patients  of ischemic group. Thus in comparing the laterality, right 
eye was more affected in non- ischemic  group  and  left eye  in ischemic 
group. 
 
IV .   DISTRIBUTION  OF  TYPE   OF  VENOUS  OCCLUSION   : 
 TABLE   7: 
        FREQUENCY       PERCENT 
NON-ISCHEMIC 
CRVO 
24 60.0 
ISCHEMIC   CRVO 12 30 .0 
 
 
CONVERTED 4 10.0 
 
In  our  study  series, among the 40 patients , 28  of them  presented  with  
non-ischemic  variety   contributing   to 60 %  of the  total  and  ischemic 
variety  contributing  to  30%   in the total  distribution. 
  Out  of  the 28  patients   in the  non-ischemic  group,  4 of them  
converted  to  ischemic  variety  at  the  end  of the  study. 
 
 
 
 
 
 
 
 
V.  CLINICAL    MANIFESTATIONS  : 
TABLE   8: 
S.NO CLINICAL  
MANIFESTATIONS 
NUMBER PERCENT 
1. SUDDEN PAINLESS 
LOSS OF  VISION 
 
25 
 
62.5% 
 
 
2. BLURRING OF VISION 17 42.5% 
3. RAPD 8 20.0% 
4. AMAUROSIS  FUGAX 3 7.5% 
5. FLASHES OF 
LIGHT,/FLOATERS 
13 32.5% 
 
   The  major  presenting  symptom  among our patients  were  sudden  
painless  visual loss contributing  to  62.5 % forming  the  major feature  
and  blurring  of  vision   to 42.5 %. Other manifestations include 
amaurosis fugax and  flashes of  light ,  floaters. 
 
 
 
 
VI.  VISUAL   ACUITY   : 
 
TABLE   9  : 
S.No VISUAL ACUITY NON-ISCHEMIC CRVO 
Initial Final 
1. 6/6 – 6/9 4 4 
 
 
2. 6/12 – 6/18 10 12 
3. 6/24 – 6/36 12 8 
4. <6/60 2 0 
5. CFCF  or WORSE 0 0 
Total 
Number 
 28 24 
 
 
In  non-ischemic group, visual acuity  at the initial presentation  
was good  with 4 patients having  6/6 – 6/9 ; 10 patients with 6 /12 – 6/18 
and  12  patients  with 6/24 – 6 /36. At the end of  the study  , majority of 
them showed no change in visual acuity. 
 
 
 
 
VISUAL ACUITY IN ISCHEMIC GROUP 
TABLE : 9 A 
 
S.No VISUAL ACUITY ISCHEMIC CRVO 
 
 
Initial Final 
1. 6/6 – 6/9 0 0 
2. 6/12 – 6/18 0 0 
3. 6/24 – 6/36 0 2 
4. <6/60 8 6 
5. CFCF  or WORSE 4 4 
Total 
Number 
 12 12 
 
In the ischemic group , majority of the patients  at the initial presentation  
had a poor  visual  acuity  of  less than 6/60. At the  end of the study , 2 
patients  showed improvement  to 6/24  - 6/ 36 , and 6 of them  showed 
no change in visual acuity. 
 
 
 
 
VISUAL ACUITY IN CONVERTED GROUP 
TABLE : 9 B 
 
 
 
S.No VISUAL ACUITY CONVERTED 
Initial Final 
1. 6/6 – 6/9 0 0 
2. 6/12 – 6/18 0 0 
3. 6/24 – 6/36 2 0 
4. <6/60 2 3 
5. CFCF  or WORSE 0 1 
Total 
Number 
 4 4 
 
In the converted group , 2 patients  at the initial presentation who  had  
visual  acuity  of 6/24 – 6/36 , at the end  had visual acuity  of less than 
6/60. The final visual acuity in this group was poor. 
 
 
 
TABLE  10  : 
S.  NON-ISCHEMIC CRVO ISCHEMIC CRVO 
 
 
NO CRITERIA FREQUENCY PERCENT FREQUENCY PERCENT 
1. SHOWED 
IMPROVEMENT IN 
VISUAL ACUITY  
(2 LINES OR   
MORE ) 
 
4 
 
16.7  % 
 
2 
 
12.5 % 
2. NO  CHANGE  IN 
VISUAL ACUITY 
 
16 
 
66.6 % 
 
6 
 
37.5 % 
3. WORSENED  ( 2  OR  
MORE  LINES) 
 
4 
 
16.7 % 
 
8 
 
50.0 % 
 
 
 
 
 
 
 
ASSOCIATED MEDICAL CONDITIONS 
 
 
TABLE   11: 
 
SL. 
NO 
MEDICAL CONDITIONS NUMBER PERCENTAGE 
1. Systemic Hypertension 16 40.0% 
2. Hyperlipidemia 6 15.0% 
3. Chronic Renal Failure 4 10.0% 
4. Coronary Artery Disease 1 2.5% 
5. Migraine 1 2.5% 
6. Anemia 2 5.0% 
7. Cerebro vascular Accident 2 5.0% 
 
A history of associated medical condition was elicited in all our 
patients. Out of which 16 patients had Systemic Hypertension which 
contributed as the single largest cause among them. 
Of the 16 patients, 3 patients were not on regular anti-Hypertensive 
therapy; 4 patients were on therapy but not on adequate dosage; 2 patients 
were detected having Hypertension  after the onset of CRVO. 
 
 
 
COMPARISION OF FREQUENCY OF 
HYPERTENSION IN NON ISCHEMIC AND 
ISCHEMIC - CRVO 
TABLE  12: 
 
S.NO CASES WITH 
HYPERTENSION 
NON-
ISCHEMIC 
CRVO 
ISCHEMIC
-CRVO 
TOTAL P-
VALUE 
1. YES 9  (32.1%) 7 (58.3%) 16  
0.1213 2. NO 19 (67.9%) 5 (41.7%) 24 
  28 (100.0%) 12 (100.0%) 40 
 
P   VALUE  =   0.1213 .This   is  not  stastically  significant. 
 
There is no statistically significant proportion in hypertension 
between Ischemic and Non Ischemic patients (P value = 0.1213). 
 
 
 
 
 
 
 
 
 
 
 
 
ASSOCIATED OCULAR CONDITIONS 
TABLE  13: 
 
SL. 
NO 
OCULAR CONDITIONS PERCENTAGE 
1. Primary Open Angle Glaucoma 5.0% 
2. Tilted Optic Nerve Head 2.5% 
3. Optic Nerve Head Drusen 0% 
 
In our study, 2 patients who presented with Non-Ischemic CRVO 
had Primary Open Angle Glaucoma . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS OF LAB STUDIES 
TABLE  14:  
 
SL. 
NO. 
LAB TESTS PERCENTAGE 
1. High Serum Cholesterol 15.68% 
2. Elevated Renal parameters 7.5% 
3. High ESR 9.8% 
4. Low Haemoglobin 5.85% 
 
 
Results of Lab investigations showed that patients above the age of 
40 years had a high level of Serum Cholesterol (more than 200 mgs%) 
than the people below 40 years. 
 
 
 
 
 
 
 
 
 
 
 
 
OCULAR SEQUELAE 
TABLE   15:  
SL. NO. OCULAR SEQUELAE PERCENTAGE 
1.  Macular Oedema 48.0% 
2. Macular Degeneration 28.92% 
3. Hard Exudates 7.69% 
4. Sheathing 4.85% 
5. Collaterals 19.0% 
6. Neovascularisation of Iris 12.5% 
7. Neovascularisation of Disc 5.0% 
8. Neovascularisation elsewhere 7.6% 
9. Neovascular Glaucoma 4.69% 
 
 The major ocular sequelae  seen in non-ischemic  CRVO 
patients was macular edema . 
 Neovascularisation of Iris was seen in 5 patients with 
Ischemic  CRVO and constituted 12.5% of all patients in the 
study.  
 Patients belonging to Non-ischaemic CRVO did not develop 
neovascular complications during the study. 
 
 
CAUSES OF POOR VISUAL RECOVERY 
TABLE   16: 
 
SL. NO CAUSES PERCENTAGE 
          1. Macular Oedema 48.09% 
2. Macular Degeneration 28.60% 
3. Macular Hard Exudates 21.42% 
4. Vitreous Haemorrhage 1.92% 
 
 Macular Oedema was the major contributing factor for poor 
visual recovery among our patients. 
 
 
                                             
 
 
 
 
 
 
 
 
 
DISCUSSION 
 This study was a non-randomised prospective study including 40 
patients with CRVO conducted in a tertiary care hospital at Madurai. 
 The aim of the study was to determine the risk factors and 
associated medical conditions of CRVO in non-diabetic individuals. All 
the patients in the study met the inclusion criteria. 
AGE DISTRIBUTION: 
 The majority of the patients in our study were in the age group of 
45 – 65 years accounting for 65% of the total. 
 In a study conducted by Hayreh et al
51
 , from 1973 through 2000, 
in 667 patients ,he found that majority of patients of Non-Ischaemic 
CRVO (559 patients) were in the age group of 65 years and older, 
contributing to 47% and patients with Ischaemic CRVO in the age group 
of more than 65 years contributed to 75%. 
 Andrew K.Vine et al 
(60)
,
  
 in his study on 74 cases found that mean 
age of presentation of CRVO was 69 years. Paul O’Mahoney
49
,  retreived 
all  studies published between January 1985 and July 2007 and found that 
most cases presented between ages 60 and 65 years. 
 
 
 In our study, the patients with Non-Ischemic CRVO at initial 
presentation were in the age group of 55 to 64 years contributing to 50% 
and patients more than 65 years contributed to 28.6% which was lower 
than the study by Hayreh et al. Patients with Ischemic CRVO in the age 
group of more than 65 years contributed to 58.3% in our study, which is 
concordant with his study. 
 
SEX DISTRIBUTION: 
 Males and females were studied for their distribution in relation to 
CRVO. 
 Based on analysis of 32 studies collected and reviewed by 
McIntosh et al
(52)
, they  found an increased incidence of CRVO in males 
contributing to  56% (1549 eyes) and 44% females (1230 eyes). It was in 
concordance with our study, where male predominance is seen than the 
females. 
Male to female ratio in our study was 30: 10, giving a ratio of 
3.0:1.0 which is slightly lower than that reported by Fong et al
(35)
 and 
Frucht. J. Yanko
(25)
 . 
 
 
 Thus a male predominance was seen in CRVO than in females and 
this may be due to the increased predisposing factors seen in males. 
 
LATERALITY: 
 CRVO is typically unilateral. In the present series, right eye was 
affected in 18 patients and left eye in 22 patients which is quite different 
from earlier reported series where the right eye was frequently involved 
as described by Hart. 
            But  study conducted by Hayreh et al
(51)
, Shows that  right eye 
was more affected in non-ischemic  and left eye  in ischemic CRVO 
individuals which was the same  in our study as right eye  in non-
ischemic was 58.4%  than 41.6 % in left eye,  in ischemic  CRVO,  left 
eye was 75 % and right eye in 25 %. 
 
 
 
 
 
 
 
 
Demographic and clinical characteristics: (Hayreh et al
(51)
  – Natural 
History of Visual outcome in CRVO) 
SL. 
NO 
EYE 
INVOLVEMENT 
NON 
ISCHEMIC 
VARIETY 
(n = 559 
eyes) 
PATIENTS  
WITH 
ISCHEMIC 
VARIETY 
(n = 109 
eyes) 
CONVERTED 
GROUP  
( n = 48 eyes) 
1. Right 266 (48%) 45 (42%) 18 (39%) 
2. Left 265 (47%) 62 (57%) 27 (59%) 
3. Both    29 (5%)    1 (1%)  1  (2%) 
  
 Recent studies have shown an equal incidence. In our series, the 
left eye involvement was slightly higher. 
 
 
 
 
 
 
 
 
CLASSIFICATION OF CRVO 
 Central Venous Occlusion is classified into 2 major types by 
Hayreh et al
(53)
, based on the combined data acquired from six tests:    
vision, visual fields examination, relative afferent pupillary defect, 
electro-retinography, ophthalmoscopy, and fundus fluorescein 
angiography. 
1) NonIschemic CRVO    or Venous Stasis Retinopathy and  
2) Ischemic CRVO or Haemorrhagic Retinopathy. 
Leber et al
(61)
,  in his study, also classified CRVO into two entities 
as Non- Ischemic CRVO and Ischemic CRVO. 
 
CONVERSION OF NON-ISCHEMIC TO ISCHEMIC CRVO: 
 McIntosh et al
(52)
, based on the analysis of 6 studies, (675 eyes) 
reported adequate quality data on the conversion of Non-ischemic to 
Ischemic CRVO. The incidence of such conversion rate from Non- 
ischemic to Ischemic CRVO ranged from 0% to 27% over a period of 10 
weeks to 13 months post CRVO. 
 
 
 In study by Hayreh et al
(51)
, which included 588 eyes with Non-
ischemic CRVO 48 eyes converted to Ischemic type;  There was a higher 
prevalence of history of Cerebro Vascular Diseases in those that 
converted as ischemic  from nonIschemicvariety. (P = 0.006). Visual 
changes after conversion to Ischemic CRVO were similar to those seen in 
eyes with Ischemic CRVO as first diagnosis. 
 In our study, out of 28 patients of Non-ischemic CRVO, 4 patients 
converted to  Ischemic CRVO, contributing to 14.28%.,this is in 
concordant with the studies observed by Mc intosh et al and Hayreh et al. 
 
VISUAL ACUITY: 
 McIntosh et al
(52)
, based on the review of 53 studies in 3271 eyes 
with CRVO found that –  For all CRVO cases, including Non ischemic 
CRVO, baseline visual acuity was generally poor (<20/40) and majority 
of studies reported a mean decrease in visual acuity over time. Ischemic 
CRVO had poor vision at presentation and follow up. Ischemic CRVO 
had a mean baseline visual acuity of 9 letters and an average decrease of 
35 letters over time compared with Non-ischemic CRVO cases, which 
had a mean baseline visual acuity of 31 letters and decrease by only 3 
letters beyond 12 months. 
 
 
 Quinlan et al
(36)
, in a retrospective study of 107 Non-ischemic and 
61 Ischemic CRVO eyes (using a criterion of more than and equal to 5 
disc diameter of capillary non-perfusion) and a follow up of 6 months to 
6 years, mean 22 months reported 15% had an improvement of 3 lines or 
more from the baseline and 31% lost 3 lines or more. 
 In all eyes with Ischemic CRVO, initial visual acuity was 20/100 
or less, the visual acuity at the end of the study was 20/200 or less in 
93%, counting fingers or less in 54%, hand movements or less in 36%. 
 Chen et al
(62)
, in a case series of 59 eyes with Non Ischemic CRVO 
followed up for at least 1 year (average 2.5 years) found that visual acuity 
improved by 2 lines or more in 15%, remained stable  in 56 % , and  
decrease by  29 %. They concluded that Non ischemic CRVO frequently 
resulted in significant permanent visual loss. They also found that initial 
visual acuity had no predictive value in prognosis. 
 Zegarra et al 
(41) 
in his  study  which  he  followed up for 1 - 8 years 
in 25 eyes, found that in 10 eyes with Non-ischemic CRVO, the visual 
acuity  at the end  was 20/30 or better in 50% and 20/60 in 30%; whereas 
among Ischemic CRVO eyes, 82% had final visual acuity of 20/400 or 
worse. 
 
 
 In our study, in Non-Ischemic CRVO,  4 patients had initial visual 
acuity of 6/6 to 6/9,  10 patients had 6/12 to 6/18, 12 patients had 6/24 to 
6/36 and 2 patients had less than 6/60. At the end of the study 4 patients 
showed an improvement in 2 lines or more, contributing to 16.7% while 
66.6 % showed no change in visual acuity and 4 patients  had visual 
acuity that worsened  by  2 lines or more. Our study results is in 
concordant with the study by Chen et al
62
 and Zegarra et al
(41)
. 
  In  Ischemic CRVO, 8 patients had an initial visual acuity of <6/60  
and 4 patients had counting fingers close to face. At the end of the study, 
2 of our patients (12.5%) showed an improvement , 6 patients (37.5%) 
showed no changes in visual acuity, and 8 patients (50.0%)  had visual 
acuity worsening of  2 lines or more. This results are in concordance with 
the studies done by Zegarra and Quinlan et al.  
 In the converted group, all patients had a final poor visual acuity of 
less than 6/60. 
 The primary cause of poor visual outcome in Non-ischemic CRVO 
is due to Macular Oedema, while in Ischemic CRVO, Retinal Ischemia 
was the major factor and Macular Oedema was minor cause. 
 In a recent SCORE (Standard Care Vs Corticosteroid for Retinal 
Vein Occlusion) study
(63) 
 in which CRVO eyes were combined into one 
 
 
group without any differentiation into Ischemic and Non-ischemic  
CRVO, in the 73 eyes with out any treatment, visual acuity improved in 
26%, remained same in 19% and deteriorated in 55% at 12 months follow 
up. 
 
NATURAL COURSE OF CRVO: 
 In a study by Hayreh et al
(51)
, the median time for Macular edema 
to resolve, was 23 months in those with Non-ischemic CRVO and 29 
months in those with Ischemic CRVO as first diagnosis.  Overall, for the 
Non-ischemic CRVO group with initial visual acuity 20/70 or worse, 
improvement was seen in 59% in which edema resolved; compared with 
26% in which edema was still present. In contrast, among eyes with 
Ischemic CRVO as first diagnosis, and initial visual acuity of 20/70 or 
worse, there was no significant association of the presence or the absence 
of Macular edema with improvement in visual acuity (P=0.55) 
McIntosh et al
(52)
, based on the analysis of 7 studies (159 eyes) 
reported the development and resolution of Macular edema over time. 
 In cases with Ischemic CRVO, the proportions that described 
resolution of Macular edema ranged from 0% to 73% over time ranging 
 
 
from 2 to 15 months post CRVO. In cases with Non-ischemic CRVO, the 
corresponding proportion was approximately 30%. In Non-ischemic 
variety, Macular edema was found to resolve in nearly 30% of patients 
over time.  
 Hayreh et al
(50)
, in a prospective study of 78 eyes with ischemic 
CRVO ,found development of any type of neovascularisation in 66.7%    
( iris NV   in 57.7%,NVG in 33.3%,angle NV  in 47.4 %,disk NV  in 1%) 
This study showed that the development of  anterior segment new vessels 
was maximum in the first 6 months and minimal after that . Browning et 
al
(64)
, in his prospective  study on  105 eyes  with ischemic crvo , found 
that 32 % developed anterior  segment  neovascularisation , 12  %  angle 
NV without   iris NV .This was also reported in 1983 by a prospective 
study of 78 eyes with ischemic CRVO. 
       In another study by Hayreh et al
(50)
, in a study comprising of 912 
subjects  ( 673 non-ischemic  and 239 ischemic ) CRVO, he found the 
probability of development of Neovascularisation of iris was  49 percent, 
new vessels at the angle  is  37 percent, NV Glaucoma 29 percent, retinal 
NV 9%.  The conclusion of the study was anterior segment 
neovascularisation was more common than posterior segment  
neovascularisation. 
 
 
 In our study, Macular edema was the major ocular sequelae, 
contributing to 48%. contributing to poor visual recovery in patients with 
Non-ischemic CRVO. Neovascularisation of iris was seen in 12.5% and 
Neovascularisation of the disc in 5.%.This is in concordant  with the 
study  conducted by Hayreh et al ,and Browning et al
(64)
, where  anterior 
segment neovascularisation was  more common  than the posterior 
segment  but the proportion was low , this may be due to  small sample 
size  observed in our study. 
Management : 
 The therapeutic regimens advocated and tried in Hayreh et al study 
includes Anticoagulants, Fibrinolytic agents, Low Molecular Weight 
Dextran, CO2 Inhalation, Vasodilators, Hyperbaric Oxygen, and Systemic 
Corticosteroids were used for resolution of Macular edema.  Another 
conclusion derived from  the study was Non-ischemic CRVO resolved 
spontaneously over time and no specific treatment was advocated as done 
in our study. 
 
ASSOCIATED   MEDICAL  CONDITIONS  :  
 
 
 Mahoney et al
(49)
, systematically retrieved all studies published 
between January 1985 and July 2007, and estimated attributable risk 
percentage for Systemic  arterial  Hypertension, Diabetes Mellitus and 
Hyperlipidemia. Of the 21 studies including 2916 cases and 28646 
controls, both Hypertesion (Odds Ratio 3.5) and Hyperlipidemia (Odds 
ratio 2.5) were significantly associated with Retinal Vein Occlusion 
occurring in any forms.. The percentage of cases with any form of Retinal 
Vein Occlusion  attributed to Hypertension was 47.99% (95% CI) to 
Diabetes Mellitus 4.9% (95% CI) and to Hyperlipidemia was 20.1% (95 
% CI). 
 Lim et al
(48)
,  in their Singapore Malay eye study in 3280 adults (40 
– 80 years) found that Retinal Vein Occlusion was associated with higher 
systolic blood pressures (age – adjusted odds ratio), higher total 
cholesterol and LDL values. 
 Sodi et al
(54)
,  in their study on 103 patients  who had CRVO  that 
was unilateral in presentation was (41 Ischemic and 62 Non-ischemic 
cases) and assessed the  percentage  of traditional Cerebro Vascular risk 
factors and found that Arterial Hypertension, Hypercholesterolemia, 
Elevated factor VIII and reduced Folic Acid levels were more frequent in 
patients with Ischemic CRVO than in Non-ischemic CRVO. 
 
 
 Hayreh et al
(51)
, in his study showed that the Ischemic CRVO group 
also had a higher prevalence of arterial Hypertension (p=0.052) and 
Diabetes Mellitus (p=0.0180) compared with Non-ischemic CRVO. 
 In our study,  Hypertension  contributed  as one of the major 
systemic risk factors for CRVO contributing to 40 % (16 cases) which is 
in concordant  with studies observed by  Mahoney et al
(49)
,  and Lim et 
al
(48)
 , but the proportion of systemic  hypertension in non- ischemic 
CRVO (9 cases)was slighty higher than ischemic CRVO( 7 cases), than 
observed in other studies. In  this  study,  P VALUE  OF (ARTERIAL 
HYPERTENSION)  was  found  to   be = 0.1213, which  is  not   
stastically  significant  and this  might be due to the  smaller sample size   
as well  as  due to lesser  duration of study. 
 
 
 
 
 
 
 
 
SUMMARY 
 
 Central Retinal Vein Occlusion is one of the Venous occlusive 
disease affecting the retina. In this study, 40 eyes of 40 patients who 
satisfied the inclusion criteria were observed. 
 Non-ischemic CRVO was observed in 28 patients and Ischemic 
CRVO in 12 patients: 4 patients from Non-ischemic CRVO 
converted to Ischemic CRVO. Majority of CRVO cases were  Non-
ischemic CRVO which was observed in most of the studies and 
also in our study. 
 Majority of the patients in Non-ischemic CRVO were in the age 
group of 55 – 64 years in our study where as the study by Hayreh 
et al
(51)
 have shown majority of Non-ischemic cases above 65 
years. In  ischemic- CRVO ,most of the patients  were above 65 
years  which  was the same in the studies by Hayreh et al. 
 Male predominance was seen in a ratio of 3.0: 1;  but it was 
slightly lower than reported by Fong et al. 
 CRVO is typically unilateral in presentation. All our cases were 
unilateral, no bilateral CRVO was reported in our study. 
 
 
 In our study, the initial and final visual acuity was generally good 
in Non-ischemic cases where as the initial visual acuity in Ischemic 
group was below 6/60. The Ischemic and Converted patients  had 
visual acuity that was poor at the end of the study, even though the 
initial visual acuity was good in the Converted group, the   final 
overall  visual acuity was poor. Many studies conducted by Hayreh 
et al
(51)
, McIntosh et al
(52)
, observed the same results. 
 In our patients, the systemic risk factors associated with CRVO 
were Systemic Hypertension, Chronic Renal Failure, 
Hyperlipidemia and Cerebro Vascular Accidents. Out of which 
Hypertension contributed as the major risk factor. Singapore Malay 
eye study
(48)
, also observed a higher association of Systolic Blood 
Pressure with CRVO. Mahoney et al
(49)
, found that both 
Hypertension and Hyperlipidemia were significantly associated 
with any form of Retinal Vein Occlusion. 
 Major ocular sequelae noted in our study was Macular edema, 
Macular degeneration, Neovascularisation of Iris and Optic disc. 
 Macular edema noted in 48% of our cases, contributed as a major 
cause of poor visual outcome in these cases. The same ocular 
sequelae was observed in studies conducted by Hayreh et al
(50)
 and 
McIntosh et al
(52)
. Neovascularisation  of iris contributed to 12.5 % 
 
 
and neovascularisation of disc and else where as 5.0 % and 7.5 %, 
Suggesting  anterior segment neovascularisation more common 
than posterior segment.  Our results were in concordant with the 
studies done by Hayreh  et al and Browning et al
(64)
. 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 This study demonstrates that,Non-ischemic CRVO contributes to  
the majority of cases of CRVO. 
 Males are  more commonly affected than females. 
 Non-ischemic CRVO was seen more commonly in the age group 
of 55-64 years while Ischemic CRVO more than 65 years. 
 The initial visual acuity in Non-ishemic CRVO was generally 
good; and majority of cases show no change in visual acuity 
through out the study. 
Macular edema accounted for the subset of visual morbidity in 
these patients. 
Macular edema resolved spontaneously over a period of time in 
Non-ischemic cases. 
 In Ischemic CRVO, the initial and final visual acuity were poor. 
The major ocular sequelae in these cases were neovascularisation 
of iris and optic disc.  
 Systemic medical conditions seen in our patients were 
Hypertension, Hyperlipidemia and Chronic Renal Failure with 
 
 
systemic Hypertension contributing to increased frequency among 
the illness. So thorough systemic evaluation has to be done in 
patients with CRVO, more than 40 years. 
  Adequate initial control of high blood pressure and cholesterol 
levels are essential.  
  Regular systemic, ophthalmologic follow up are important in early 
diagnosis of the disease as well as monitoring the progression of 
the disease. 
 It is important for all patients with  systemic illness  like 
hypertension , hyperlipidemia ,coronary artery disease and chronic 
renal failure to undergo ophthalmological evaluvation regularly  
since early diagnosis  and regular  follow-up  can  reduce  the 
deterioration of vision occurring due to the ocular sequelae in these 
patients. 
 
 
 
 
 
 
 
 
GENDER STUDY GROUP 
CHART  1 
 
 
 
 
 
 
 
 
 
 
75%
25%
Male 
Female 
 
 
 
CHART  2 
 
 
 
 
 
 
 
 
 
 
 
 
 
71.4
83.3
28.6
17.7
0
10
20
30
40
50
60
70
80
90
Non-ischemic  CRVO Ischemic- CRVO
Male
Female
 
 
 
AGE  - STUDY  GROUP 
CHART  3 
 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
45
35  - 44 45  - 54 55 - 64 65  - 74
5%
25%
45%
25%
 
 
INITIAL PRESENTATION 
CHART  4 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
35  - 44 45  - 54 55  - 64 65   - 75
 
 
LATERALITY 
CHART  5 
 
 
 
 
 
 
 
 
 
 
45%
55%
RIGHT EYE
LEFT  EYE
 
 
CHART  6 
 
 
 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
NON-ISCHEMIC CRVO ISCHEMIC- CRVO CONVERTED
14
3
1
10
9
3
Fr
eq
u
en
cy
Type of CRVO
 
 
DISTRIBUTION  OF  TYPE   OF  VENOUS  OCCLUSION    
CHART  7 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
NON-ISCHEMIC CRVO ISCHEMIC   CRVO CONVERTED
 
 
CLINICAL MANIFESTATIONS   
CHART  8 
 
 
 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
SUDDEN PAINLESS 
LOSS OF  VISION
BLURRING OF 
VISION
RAPD AMAUROSIS  
FUGAX
FLASHES OF 
LIGHT,/FLOATERS
25
17
8
3
13
 
 
VISUAL ACUITY 
CHART  9 
 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
6/6 -6/9 6/12 – 6/18 6/24 - 6/36 <  6/60 CFCF  or WORSE
4
10
12
2
0
0
0
0
8
4
4
12 8
0
0
0
0
2
6
4
0
3
1
INITIAL NON-ISCHEMIC 
CRVO
INITIAL ISCHEMIC-
CRVO
FINAL NON-ISCHEMIC 
CRVO
FINAL ISCHEMIC-CRVO
FINAL CONVERTED
 
 
VISUAL ACUITY 
CHART  10 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
18
SHOWED 
IMPROVEMENT IN 
VISUAL ACUITY  (  2 
LINES OR  MORE ) 
NO  CHANGE  IN 
VISUAL ACUITY
WORSENED  ( 2  OR  
MORE  LINES)
NON-ISCHEMIC CRVO
ISCHEMIC CRVO
 
 
 
ASSOCIATED MEDICAL CONDITIONS 
CHART  11 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
16
6
4
1 1
2 2
 
 
COMPARISION OF FREQUENCY OF HYPERTENSION 
IN NON ISCHEMIC AND ISCHEMIC - CRVO   
CHART  12 
 
 
 
 
 
 
 
 
9
7
19
5
0 5 10 15 20
NON-ISCHEMIC CRVO 
ISCHEMIC-CRVO
NO
YES
 
 
 
ASSOCIATED OCULAR CONDITIONS 
 
CHART - 13 
 
 
 
 
 
 
 
 
 
5.00%
2.50%
0%
0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
6.00%
Primary Open Angle 
Glaucoma
Tilted Optic Nerve Head Optic Nerve Head Drusen
 
 
RESULTS OF LAB STUDIES 
CHART  14 
 
 
 
 
 
 
 
 
15.68%
7.50%
9.80%
5.85%
0.00%
2.00%
4.00%
6.00%
8.00%
10.00%
12.00%
14.00%
16.00%
18.00%
High Serum 
Cholesterol
Elevated Renal 
parameters
High ESR Low Haemoglobin
 
 
OCULAR SEQUELAE 
CHART  15 
 
 
 
 
 
 
 
48.00%
28.92%
7.69%
4.85%
19.00%
12.50%
5.00%
7.60%
4.69%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
 
 
 
CAUSES OF POOR VISUAL RECOVERY 
CHART  16 
 
 
 
 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00%
Macular Oedema Macular 
Degeneration
Macular Hard 
Exudates
Vitreous 
Heamorrhage
48.09%
28.60%
21.42%
1.92%
 
 
 
 
 ANNEXURE 
CRVO - Central Retinal Vein Occlusion 
HCRVO - Hemi Central Retinal Vein Occlusion 
BRVO - Branch Retinal Vein Occlusion 
HCY  - Homocysteine  
SLE  - Systemic Lupus Erythematosus 
OR  - Odds Ratio 
C.I  - Confidence Intervals 
RVO  - Retinal Vein Occlusion 
CFCF  - Counting Fingers Close to Face 
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PROFORMA 
Name :    Age    Sex 
 
OP No. 
 
History: 
 Chief Complaints 
 Less than 6 months 
 Duration    
 More than 6 months 
 History of Presenting illness 
 Past History:      Yes    No 
 Duration 
 H/o Hypertension 
 H/o Coronary artery Disease 
 H/o Chronic Renal failure  
(Renal Disease) 
 H/o Malignancy 
 
 
 
 H/o Vascular Occlusive events   Yes   No
 Duration 
Eg : Cerebro Vascular Infarcts 
 H/o Chronic Liver Disease  
 H/o Drug Intake 
 H/o Trauma 
 H/o Previous Intra ocular  Surgery 
 H/o Previous Photo coagulation Procedures 
 H/o Migraine 
 H/o Oral Contraceptive usage ( in femals) 
 Chronic illness like tuberculosis, HIV 
 Personal H/o     Yes  No
 Duration 
 Smoking 
 Alcohol 
 Physical Activity 
 Diagnosis: 
 
 Eye: 
 
 
1. Right 
2. Left 
3. Both 
 
 Ocular Examination (Both Eyes) 
 Distance 
1. Visual Acuity  
- Best Corrected Near 
2. Visual fields    
3. Pupillary reaction  1.Normal   2.Abnormal 
4. Introcular pressure  
5. Anterior Segment – Examination 
o Slit lamp Examination 
o Gonioscopy 
6. Posterior Segment 
- Slit lamp Biomicroscopy with +90 D 
- Indirect ophthalmoscopy. 
7. Fundus flourescein angiography 
8. Fundus Photographs 
 
 
Follow up
 
 
 
 
 
S.NO NAME AGE SEX OP. NO TYPE OF CRVO LATERALITY VISUAL ACUITY SYSTEMIC DISEASES
CLINICAL MANIFESTATIONS
INITIAL FINAL
1 KOORU AMBALAM 47 M 536956 NON-ISCHEMIC RIGHT EYE 6/18 6/12 HYPERLIPIDEMIA
SUDDEN PAINLESS LOSS OF 
VISION,BLURRING OF VISION 
2 SONAIMUTHU 52 M 546800 NON- ISCHEMIC LEFT EYE 6/36 5/60
-
SUDDEN PAINLESS LOSS OF VISION, 
FLOATERS
3 MUTHU KALAI THEVAR 62 M 521364 ISCHEMIC LEFT EYE 5/60 6/24
SYSTEMIC HYPERTENSION
SUDDEN PAINLESS LOSS OF VISION, 
BLURRING OF VISION, FLOATERS
4 KARUPAYEE 49 F 510482 NON-ISCHEMIC LEFT EYE 6/24 6/12
- BLURRING OF VISION, FLOATERS
5 RAJAKARUTHAI 56 M 536804 NON-ISCHEMIC RIGHT EYE 6/36 6/18
SYSTEMIC HYPERTENSION
SUDDEN PAINLESS LOSS OF VISION, FLASHES 
OF LIGHT
6 SEKAPI 46 F 516809 NON-ISCHEMIC LEFT EYE 6/6 6/9 HYPER LIPIDEMIA
BLURRING OF VISION, SUDDEN PAINLESS 
LOSS OF VISION
7 BEER MOHAMMED 68 M 540028 NON-ISCHEMIC LEFT EYE 5/60 2/60 CORONARY ARTERY DISEASE
SUDDEN PAINLESS LOSS OF VISION, 
AMAUROSIS FUGAX.
8 JEGATHEESWARAN 42 M 504220 NON-ISCHEMIC RIGHT EYE 6/12 6/9 HYPER LIPIDEMIA
BLURRING OF VISION, SUDDEN PAINLESS 
LOSS OF VISION
9 RAMAIH 50 M 561284 NON-ISCHEMIC RIGHT EYE 6/18 6/12
SYSTEMIC HYPERTENSION BLURRING OF VISION
10 OTCHA THEVAR 65 M 533602 ISCHEMIC LEFT EYE 2/60 6/60
SYSTEMIC HYPERTENSION
SUDDEN PAINLESS LOSS OF VISION, RAPD 
PRESENT
MASTER CHART
11 VEERA LAKSHMI 65 F 534024 ISCHEMIC RIGHT EYE 3/60 6/60
SYSTEMIC HYPERTENSION
SUDDEN PAINLESS LOSS OF VISION, RAPD 
PRESENT
12 RAMAR 52 M 520016 NON-ISCHEMIC RIGHT EYE 6/18 6/24
- BLURRING OF VISION
13 PARAMAN 58 M 510985 NON-ISCHEMIC RIGHT EYE 6/36 6/18
SYSTEMIC HYPERTENSION
BLURRING OF VISION, SUDDEN PAINLESS 
LOSS OF VISION
14 PITCHAIKAL 40 M 551842 NON-ISCHEMIC LEFT EYE 6/12 6/9
CHRONIC RENAL FAILURE SUDDEN PAINLESS LOSS OF VISION
15 KATHAYEE 48 F 560426 NON-ISCHEMIC LEFT EYE 6/9 6/18
HYPER LIPIDEMIA SUDDEN PAINLESS LOSS OF VISION
16 MUTHUSAMY 48 M 551265 NON-ISCHEMIC RIGHT EYE 6/24 6/36
- BLURRING OF VISION
17 PANCHAVARNAM 60 F 509874 NON-ISCHEMIC RIGHT EYE 6/24 6/36
SYSTEMIC HYPERTENSION
SUDDEN PAINLESS LOSS OF VISION; 
FLOATERS PRESENT
18 AYYAVU 68 M 546894 ISCHEMIC LEFT EYE 1/60 4/60
CERBRO VASCULAR 
ACCIDENT
SUDDEN PAINLESS LOSS OF VISION; RAPD 
PRESENT
19 SELVARAJ 49 M 538250 NON-ISCHEMIC LEFT EYE 6/18 6/12 -
BLURRING OF VISION.
20 RAJAMMAL 56 F 504862 NON-ISCHEMIC LEFT EYE 6/36 6/36
SYSTEMIC HYPERTENSION FLOATERS PRESENT.
21 ABUKKAR 56 M 566891 NON-ISCHEMIC RIGHT EYE 6/9 6/12
SYSTEMIC HYPERTENSION BLURRING OF VISION
22 MUTHURAMAN 52 M 516250 ISCHEMIC RIGHT EYE 5/60 6/36
CHRONIC RENAL FAILURE
SUDDEN PAINLESS LOSS OF 
VISION,FLOATERS PRESENT
23 LAKSHMANAN 62 M 584050 NON-ISCHEMIC RIGHT EYE 6/60 HM+
CERBRO VASCULAR 
ACCIDENT
AMAUROSIS FUGAX; SUDDEN PAINLESS 
LOSS OF VISION
24 PERUMAYEE 61 F 526324 ISCHEMIC LEFT EYE 4/60 1/60
MIGRAINE
SUDDEN PAINLESS LOSS OF VISION, RAPD 
PRESENT
25 PANDIAN 70 M 586020 ISCHEMIC RIGHT EYE PL,PR + PL,PR+
CHRONIC RENAL FAILURE
SUDDEN PAINLESS LOSS OF VISION, RAPD 
PRESENT
26 SOMU 58 M 594274 NON-ISCHEMIC RIGHT EYE 6/24 6/24
 - FLOATERS PRESENT
27 CHINNA SAMY 72 M 506270 ISCHEMIC LEFT EYE CFCF PL,PR+
SYSTEMIC HYPERTENSION BLURRING OF VISION,RAPD PRESENT
28 KARUNAKARAN 59 M 514254 NON-ISCHEMIC LEFT EYE 6/12 6/24
HYPER LIPIDEMIA BLURRING OF VISION, FLOATERS PRESENT
29 VELAMMAL 69 F 556274 NON-ISCHEMIC LEFT EYE 6/36 5/60
ANEMIA WITH SYSTEMIC 
HYPERTENSION,
SUDDEN PAINLESS LOSS OF VISION, 
FLOATERS
30 THANGAVEL 62 M 573240 NON-ISCHEMIC RIGHT EYE 6/18 6/12
ANEMIA 
SUDDEN PAINLESS LOSS OF VISON, 
FLOATERS
31 RAMAIYA THEVAR 69 M 566220 ISCHEMIC LEFT EYE 3/60 6/60
SYSTEMIC HYPERTENSION BLURRING OF VISION WITH RAPD
32 MANIKANDAN 68 M 570238 ISCHEMIC LEFT EYE 1/60 5/60
SUDDEN PAINLESS LOSS OF VISION.
33 KALIAPPAN 62 M 524082 NON-ISCHEMIC RIGHT EYE 6/12 6/12
SYSTEMIC HYPERTENSIO BLURRING OF VISION
34 MUNIYANDI 67 M 535082 ISCHEMIC LEFT EYE HM+ PL,PR+
SYSTEMIC HYPERTENSION
SUDDEN PAINLESS LOSS OF VISION,RAPD 
PRESENT
35 KATHAYEE 62 F 540875 NON-ISCHEMIC RIGHT EYE 6/36 6/12
HYPER LIPIDEMIA AMAUROSIS FUGAX
36 ALAGAR SAMY 60 M 560891 ISCHEMIC LEFT EYE CFCF HM+
SYSTEMIC HYPERTENSION SUDDEN PAINLESS LOSS OF VISION
37 CHANDRAN 56 M 52616 NON-ISCHEMIC LEFT EYE 6/24 6/60
- BLURRING OF VISION, FLOATERS
38 VELLAI SAMY 60 M 531842 NON-ISCHEMIC RIGHT EYE 6/9 6/24
CHRONIC RENAL FAILURE SUDDEN PAINLESS LOSS OF VISION
39 MARUTHAN 69 M 540265 NON-ISCHEMIC LEFT EYE 6/36 5/60
SYSTEMIC HYPERTENSION
SUDDEN PAINLESS LOSS OF VISION, 
FLOATERS
40 RAKKAYEE 58 F 597248 NON-ISCHEMIC LEFT EYE 6/18 6/18
- BLURRING OF VISION
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